The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-06-24), PureTech Health's 14-Day RSI is 54.09.
The industry rank for PureTech Health's 14-Day RSI or its related term are showing as below:
PRTCY's 14-Day RSI is ranked worse than 72.14% of 1425
companies
in the Biotechnology industry
Industry Median: 45.85
vs PRTCY: 54.09
PureTech Health (OTCPK:PRTCY) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
PureTech Health 14-Day RSI Related Terms
PRTCY vs VRTX, REGN, ALNY: 14-Day RSI Comparison
For the Biotechnology subindustry, PureTech Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PureTech Health 14-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PureTech Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where PureTech Health's 14-Day RSI falls into.
PureTech Health (OTCPK:PRTCY) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PureTech Health (PRTCY) has a 14-Day RSI of 54.09 as of Jun. 24, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on PureTech Health and its competitors. According to the industry distribution chart, PureTech Health ranks #1028 out of 1425 companies in the Biotechnology industry, placing it in the top 72.1%.
Is PureTech Health's 14-Day RSI too high?
PureTech Health's current 14-Day RSI is 54.09. The Biotechnology industry median 14-Day RSI is 45.85. PureTech Health's value of 54.09 is 18% above this industry median. Based on the distribution chart, PureTech Health ranks #1028 out of 1425 companies in the Biotechnology industry, which is below the industry midpoint. Overall, PureTech Health has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PureTech Health's 14-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PureTech Health ranks #1028 out of 1425 companies for 14-Day RSI. This places PureTech Health in the lower half of its industry. The industry median 14-Day RSI is 45.85. PureTech Health's value of 54.09 is 18% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Biotechnology company?
The median 14-Day RSI among Biotechnology companies is 45.85, based on 1,425 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PureTech Health's current 14-Day RSI of 54.09 is 18% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on PureTech Health and its competitors. For the Biotechnology industry, the median 14-Day RSI is 45.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PureTech Health's current 14-Day RSI is 54.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PureTech Health stock overvalued right now?
Based on GuruFocus' analysis, PureTech Health (PRTCY) is currently considered Possible Value Trap. The stock's GF Value™ is $70.09, compared to a current price of $17.54 — trading 75% below its estimated fair value. The current 14-Day RSI is 54.09 and 18% above the Biotechnology industry median of 45.85. PureTech Health's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For PureTech Health (PRTCY), the current 14-Day RSI is 54.09 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PureTech Health (PRTCY) Overvalued in 2026?
Based on GuruFocus' analysis, PureTech Health stock appears to be undervalued.
The current stock price of $17.54 is trading 75% below its estimated GF Value™ of $70.09.
GuruFocus considers PureTech Health to be Possible Value Trap.
Key valuation signals for PRTCY:
14-Day RSI: 54.09
GF Value™: $70.09 vs. price of $17.54 (75% below fair value)
Industry Position: 18% above the Biotechnology median (#1028 of 1425)
No single metric tells the full story. See the PRTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
62GF Score
Get the complete analysis for PRTCY
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRTCY has been successfully added to your 